Evaluation of Cardiovascular Outcomes in Patients With Type 2 Diabetes After Acute Coronary Syndrome During Treatment With AVE0010 (Lixisenatide)
Condition(s):Acute Coronary SyndromeLast Updated:December 20, 2016Completed
Hide Studies Not Open or Pending
Condition(s):Acute Coronary SyndromeLast Updated:December 20, 2016Completed
Condition(s):Non-Small Cell Lung CancerLast Updated:September 25, 2019Completed
Condition(s):SchizophreniaLast Updated:April 2, 2015Completed
Condition(s):Non-small-cell Lung CancerLast Updated:April 19, 2017Completed
Condition(s):Type 2 DiabetesLast Updated:January 26, 2017Completed
Condition(s):Non-Squamous Non-Small Cell Lung CancerLast Updated:April 19, 2017Completed
Condition(s):Diabetes Mellitus, Type 2Last Updated:May 16, 2016Completed
Condition(s):Acute Coronary SyndromeLast Updated:October 31, 2012Terminated
Condition(s):Femur Neck FractureLast Updated:April 16, 2015Completed
Condition(s):Femur Neck FractureLast Updated:April 16, 2015Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.